• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Hygienic Packaging Technology

    Trends in Solid Oral Dosage Delivery

    5 Reasons Paper Has No Place in Contract Manufacturing

    Injectable Drug Delivery Trends

    Pharmaceutical Manufacturing Equipment Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Aptamer Extends Collaboration with AstraZeneca

    Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark

    Reed-Lane Facility Virtual Tour
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reed-Lane Facility Virtual Tour

    Hygienic Packaging Technology

    Reshaping the Pharmaceutical Supply Chain

    Serialization: Level 5 Solution

    Covectra Introduces Next-Gen Serialization Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Data Management Trends

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Aptamer Extends Collaboration with AstraZeneca
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Adare Pharma Solutions

    Syngene

    Cytovance Biologics

    Emergent BioSolutions

    PCI Pharma Services
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Cytovance Biologics

    Almac Group

    Emergent BioSolutions

    Reed-Lane

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Alvotech and DKSH Extend Biosimilar Partnership in Asia

    Initial pipeline contains biosimilar candidates addressing multiple therapeutic areas.

    Related CONTENT
    • Asymchem and Snapdragon Enter Investment Partnership
    • Exelixis and Catalent Enter ADC Partnership
    • Siemens, Perceptive Engineering & PSE Join Medicines Manufacturing Innovation Centre
    • Parexel, Pfizer Extend Long-Term Partnership
    • ForDoz, Lupin Enter Injectables Partnership
    Contract Pharma Staff09.24.20
    Alvotech and DKSH, a healthcare provider across 36 emerging countries in South-East Asia, have expanded their partnership to commercialize six new biosimilar product candidates for the Asian markets. The initial pipeline contains biosimilar candidates addressing multiple therapeutic areas.
     
    “We have been delighted to work with DKSH since our initial partnership began earlier this year,” said Mark Levick, chief executive officer, Alvotech. “The partnership is designed to accelerate improved patient access for high quality biosimilar medicines in the Asian biosimilar industry. This is also another milestone for Alvotech, where we continue to extend our network of leading commercial partners around the globe.”
     
    In March 2020, the companies announced its exclusive partnership agreement for AVT02, an adalimumab biosimilar, a leading drug indicated for the treatment of several autoimmune diseases. The collaboration includes the following markets: Taiwan, Korea, Hong Kong, Philippines, Vietnam, Thailand, Cambodia, Myanmar, Malaysia, Singapore, Indonesia, India, Bangladesh and Pakistan. These biosimilar candidates’ brand values are estimated around $1.5 billion in annual sales in the Asia Pacific region, according to IQVIA data. 
     
    Bijay Singh, global head of business unit healthcare, DKSH, said, “The extended partnership with Alvotech demonstrates our commitment to bringing high-quality medical products to Asian patients and enriching their lives. At DKSH, we believe biosimilars offer a tremendous opportunity to enhance the standard of care in several disease areas across the Asian markets. This partnership brings together two strong players—Alvotech, with their leading position in the development and manufacturing of biosimilars worldwide, and DKSH as the leading commercial outsourcing partner for healthcare companies in Asia.”
     
    This latest announcement from Alvotech and DKSH expands on a deep partnership between the two companies to accelerate the introduction of high quality biosimilar to patients in Asia. In the last twelve months, Alvotech has made strategic partnership agreements with leading regional and global industry players including: Teva in the U.S., Stada in Europe, JAMP in Canada, Yas Holding in the Middle East and Fuji Pharma in Japan.
    Related Searches
    • Biosimilars
    Suggested For You
    Asymchem and Snapdragon Enter Investment Partnership Asymchem and Snapdragon Enter Investment Partnership
    Exelixis and Catalent Enter ADC Partnership Exelixis and Catalent Enter ADC Partnership
    Siemens, Perceptive Engineering & PSE Join Medicines Manufacturing Innovation Centre Siemens, Perceptive Engineering & PSE Join Medicines Manufacturing Innovation Centre
    Parexel, Pfizer Extend Long-Term Partnership Parexel, Pfizer Extend Long-Term Partnership
    ForDoz, Lupin Enter Injectables Partnership ForDoz, Lupin Enter Injectables Partnership
    RedHill and Cosmo Pharmaceuticals Expand Strategic Partnership RedHill and Cosmo Pharmaceuticals Expand Strategic Partnership
    Bright Path Laboratories selects TrackWise Digital QMS Bright Path Laboratories selects TrackWise Digital QMS
    Caprion-HistoGeneX Partners with Viroclinics-DDL Caprion-HistoGeneX Partners with Viroclinics-DDL
    Avacta Partners with BBI Solutions Avacta Partners with BBI Solutions
    Activ-BlisterTM solutions in partnership with CSP Technologies Activ-BlisterTM solutions in partnership with CSP Technologies
    ViralClear, AMRI Enter COVID-19 Partnership ViralClear, AMRI Enter COVID-19 Partnership
    CEPI Expands Partnership with Clover CEPI Expands Partnership with Clover
    Rentschler Biopharma and Vetter Enter Partnership Rentschler Biopharma and Vetter Enter Partnership
    Aligos Therapeutics and KU Leuven to Collaborate Aligos Therapeutics and KU Leuven to Collaborate
    Fujifilm, Dr. Reddy’s and Global Response Aid Enter COVID-19 Partnership Fujifilm, Dr. Reddy’s and Global Response Aid Enter COVID-19 Partnership

    Related Breaking News

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
      Alvotech, DKSH Partner to Bring Biosimilar to Asia

      Alvotech, DKSH Partner to Bring Biosimilar to Asia

      Biosimilar of AbbVie’s Humira to be developed and supplied by Alvotech
      03.26.20

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
      Alvotech, JAMP Pharma Ink Biosim Deal

      Alvotech, JAMP Pharma Ink Biosim Deal

      Enter into an exclusive partnership for the commercialization of key biosimilars in Canada.
      01.15.20

    • Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
      Horizon, Glenmark Sign Biomfg. License Agreement

      Horizon, Glenmark Sign Biomfg. License Agreement

      For GS knockout CHO cell line for manufacture of biotherapeutics
      09.30.19


    • Bio News | Biosimilars | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
      Lonza, Celltrion Sign Contract to Manufacture Remsima Drug Substance

      Lonza, Celltrion Sign Contract to Manufacture Remsima Drug Substance

      Lonza’s biologics facility in Singapore to cover EU and U.S. market needs
      09.03.19

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
      Alvotech, Prestige Biopharma Enter New Manufacturing Partnership

      Alvotech, Prestige Biopharma Enter New Manufacturing Partnership

      Alvotech Contract Services to make one of Prestige’s biosimilar candidates
      08.28.19

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
      Alvotech, Cipla Gulf Ink Biosimilar Deal

      Alvotech, Cipla Gulf Ink Biosimilar Deal

      Will partner for the commercialization of key biosimilar in select emerging markets
      07.29.19


    • Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News | Collaborations & Alliances | Facilities | Industry News
      Celltrion, Nan Fung Group Set Up Bio CDMO in China

      Celltrion, Nan Fung Group Set Up Bio CDMO in China

      Establish Vcell Healthcare to develop and commercialize biosimilars; will open biologics manufacturing facility
      07.19.19

    • Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News
      BioPlan Benchmarks the State of Biopharma Mfg.

      BioPlan Benchmarks the State of Biopharma Mfg.

      Participate in the 16th Annual Biopharma Survey Report!
      03.08.19

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      Selexis, Turgut Expand Biosimilar Development Pact

      Selexis, Turgut Expand Biosimilar Development Pact

      Under new commercial license agreements, Selexis will help advance Turgut’s pipeline of biosim products in oncology
      02.28.19


    • Bio News | Biosimilars | Breaking News
      Samsung Bioepis, C-Bridge Capital to Develop Next-Gen Biosims in China

      Samsung Bioepis, C-Bridge Capital to Develop Next-Gen Biosims in China

      C-Bridge forms new biopharmaceutical company, AffaMed Therapeutics, which will collaborate with Samsung Bioepis
      02.11.19

    • Bio News | Biosimilars | Breaking News | Industry News
      Alvotech Raises $300M to Fuel Biosimilar Growth

      Alvotech Raises $300M to Fuel Biosimilar Growth

      Current pipeline consists of six biosimilar monoclonal antibodies aimed at treating cancer, autoimmune, inflammatory and other diseases
      01.22.19

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
      Sandoz Enters Biosimilars Deal with Gan & Lee Pharmaceutical in China

      Sandoz Enters Biosimilars Deal with Gan & Lee Pharmaceutical in China

      Covers biosimilar insulins in early and clinical development for the top three selling branded insulins by sales: glargine, lispro and aspart
      12.28.18


    • Biosimilars | Breaking News | Drug Development | Industry News
      Alvotech, Fuji Pharma Expand Biosimilars Alliance

      Alvotech, Fuji Pharma Expand Biosimilars Alliance

      Fuji invests $50 million in Alvotech, expands development and commercialization of biosimilars in Japan
      12.18.18

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
      Alvotech and Fuji Pharma Enter Biosimilars Tie-up

      Alvotech and Fuji Pharma Enter Biosimilars Tie-up

      Partnership gives Fuji Pharma a leading position in the Japanese biosimilar market
      11.20.18

    • Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News | cGMP Manufacture | Industry News
      REPORT: Biopharma Mfg. Capacity and Production

      REPORT: Biopharma Mfg. Capacity and Production

      222 biopharma companies surveyed plus130 industry vendors and direct suppliers of materials
      08.17.18

    Trending
    • Four Female Leaders Appointed To Cell & Gene CDMO
    • BMS Expands Cell Therapy Manufacturing Capabilities
    • Reed-Lane Facility Virtual Tour
    Breaking News
    • AGC Biologics Expands Cell and Gene Facility in Italy
    • Celonic to Boost Cell & Gene Therapy Production
    • Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    • Aptamer Extends Collaboration with AstraZeneca
    • Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Hygienic Packaging Technology
    • Trends in Solid Oral Dosage Delivery
    • 5 Reasons Paper Has No Place in Contract Manufacturing
    • Injectable Drug Delivery Trends
    • Pharmaceutical Manufacturing Equipment Trends
    • Oral Solids: Market & Technology Trends
    • Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow
    • 2021 Contract Manufacturing Survey
    • Small Molecule Development Trends
    • Challenges & Opportunities Facing Small & Emerging Biopharma Companies
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Thymoquinone Inhibits Viral Infection in In Vitro Settings, New Study Finds
    IFT Transitions 2021 Annual Event to Digital Experience
    NY Federal Judge Enters Permanent Injunction Against Dietary Supplement Manufacturer
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Announces Resignation of President, COO
    Ashland Completes Expansion, Relocation of Viatel Bioresorbable Polymers Manufacturing Facility
    Evonik Receives Sustainability Award from EcoVadis
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cretex CFO Announces Retirement
    New AI-Based Tool Developed for Coronary Artery Analysis, Intervention Planning
    First Reported Use of Pulse Biosciences' CellFX System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AGC Biologics Expands Cell and Gene Facility in Italy
    Celonic to Boost Cell & Gene Therapy Production
    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Ulta Beauty Opens in Herald Square
    Elizabeth Arden Taps Sui He as Global Brand Ambassador
    Natura &Co Outperforms the Global Market in Q4 2020
    Happi

    Latest Breaking News From Happi

    What You're Reading on Happi.com
    Indie Beauty Innovators Wanted
    Cosmetic Chemists Seek Mentors
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Arjobex America welcomes Maggie Naberezny to sales team
    Henkel publishes 30th Sustainability Report
    Avery Dennison Smartrac launches new Circus Pro inlays
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    FPInnovations Develops Biodegradable Mask
    Sani Professional Sanitizing and Disinfecting Products Approved by EPA
    Autefa Solutions Offers Fully Automated Line for Protective Mask Production
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Colfax Decides to Divide Its Businesses
    Stryker Corp.'s 2020 Sales Slip 3.6 Percent
    Bioventus Appoints Managing Director, China and Asia Pacific
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login